In treatment of inflammatory bowel disease (IBD), diet may play an increasingly important role as a therapy.
A new study “Diet to Induce Remission in Crohn’s Disease,” or DINE-CD, compared the Specific Carbohydrate Diet and the Mediterranean Diet in terms of efficacy and safety in patients.
As it turned out, both diets met symptomatic remission in nearly half of patients, in 43.5% of patients following a Mediterranean style diet and 46.5% of patients following the Specific Carbohydrate Diet.
In this episode of the DocTalk podcast, lead investigator of the DINE-CD, James Lewis, MD, Chief of Gastroenterology at Penn Presbyterian Medical Center, discussed the reasons behind the diets chosen and what they might ultimately mean for care for patients with IBD.
